The legacy of Viagra, and its creator copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its dominance. While certain firms may attempt to capitalize on male sexual dysfunction